The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles

J Biol Chem. 2021 Jan-Jun:296:100111. doi: 10.1074/jbc.RA120.016175. Epub 2020 Dec 3.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a β-coronavirus, is the causative agent of the COVID-19 pandemic. Like for other coronaviruses, its particles are composed of four structural proteins: spike (S), envelope (E), membrane (M), and nucleoprotein (N) proteins. The involvement of each of these proteins and their interactions are critical for assembly and production of β-coronavirus particles. Here, we sought to characterize the interplay of SARS-CoV-2 structural proteins during the viral assembly process. By combining biochemical and imaging assays in infected versus transfected cells, we show that E and M regulate intracellular trafficking of S as well as its intracellular processing. Indeed, the imaging data reveal that S is relocalized at endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) or Golgi compartments upon coexpression of E or M, as observed in SARS-CoV-2-infected cells, which prevents syncytia formation. We show that a C-terminal retrieval motif in the cytoplasmic tail of S is required for its M-mediated retention in the ERGIC, whereas E induces S retention by modulating the cell secretory pathway. We also highlight that E and M induce a specific maturation of N-glycosylation of S, independently of the regulation of its localization, with a profile that is observed both in infected cells and in purified viral particles. Finally, we show that E, M, and N are required for optimal production of virus-like-particles. Altogether, these results highlight how E and M proteins may influence the properties of S proteins and promote the assembly of SARS-CoV-2 viral particles.

Keywords: COVID-19; SARS-CoV; glycoprotein; infectious disease; secretion; viral protein; virus assembly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomimetic Materials / chemistry
  • Biomimetic Materials / metabolism
  • Cell Line, Tumor
  • Chlorocebus aethiops
  • Coronavirus Envelope Proteins / genetics*
  • Coronavirus Envelope Proteins / metabolism
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum / ultrastructure
  • Endoplasmic Reticulum / virology
  • Gene Expression
  • Golgi Apparatus / metabolism
  • Golgi Apparatus / ultrastructure
  • Golgi Apparatus / virology
  • HEK293 Cells
  • Hepatocytes / metabolism
  • Hepatocytes / ultrastructure
  • Hepatocytes / virology
  • Host-Pathogen Interactions / genetics
  • Humans
  • Nucleocapsid Proteins / genetics*
  • Nucleocapsid Proteins / metabolism
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / growth & development*
  • SARS-CoV-2 / metabolism
  • Spike Glycoprotein, Coronavirus / genetics*
  • Spike Glycoprotein, Coronavirus / metabolism
  • Vero Cells
  • Viral Matrix Proteins / genetics*
  • Viral Matrix Proteins / metabolism
  • Virion / genetics
  • Virion / growth & development*
  • Virion / metabolism
  • Virus Assembly / physiology*
  • Virus Internalization
  • Virus Release / physiology

Substances

  • Coronavirus Envelope Proteins
  • Nucleocapsid Proteins
  • Recombinant Proteins
  • Spike Glycoprotein, Coronavirus
  • Viral Matrix Proteins
  • envelope protein, SARS-CoV-2
  • membrane protein, SARS-CoV-2
  • spike protein, SARS-CoV-2